Emerging Diagnostic Biomarkers in Ovarian Cancer

Table of Contents

• Overview
• Pathophysiology of Ovarian
  • Cancer
  • Characterization of Ovarian Epithelial
  • Tumors
• Spread of Ovarian
  • Cancer
  • Staging
• Prognostic
  • Factors
  • Tumor Stage
  • Peritoneal Fluid Cytology
  • Tumor Histology
  • Performance Status
  • Age
  • Volume of Residual Disease
  • CA-125 Levels
  • DNA Ploidy
• Current Ovarian Cancer
  • Screening
• Current Ovarian Cancer
  • Diagnosis
• Value of a Biomarker for Ovarian
  • Cancer
• Technologies Used to Identify Ovarian Cancer
  • Biomarkers
  • Proteomics
  • Genomics
• Emerging
  • markers
• Biomarker
  • Development
• Improving Clinical Trial
  • Design
• Patient-Tailored
  • Therapy
  • Outlook

• Table 1 International Federation of Gynecology and Obstetrics (FIGO) Staging System for Primary Carcinoma of the Ovary
• Table 2 Select Emerging Biomarkers for the Diagnosis of Ovarian Cancer
• Table 3 Serum Biomarkers Evaluated for Their Ability to Detect Ovarian Cancer
• Table 4 Ongoing U.S. Clinical Trials Investigating Screening and Diagnostic Methods for Ovarian Cancer